# Highsun Holdings to acquire Fibrant's caprolactam business from DSM and CVC

Fibrant Holding BV announced the proposed sale of Fibrant BV and 60% of Fibrant China to Highsun Holdings Group Ltd. DSM, which indirectly owns 35% of Fibrant BV, expects to receive about €200 million from the transaction, expected to close in Q3 2018.

- Type: Acquisition
- Announced: 2018-05-17
- Where: Netherlands
- Value: $235.0M (200.0M EUR)
- Status: announced
- Products: caprolactam, polyamide 6
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [CVC Capital Partners](https://endata.com/companies/226.md) (partner)
- [DSM](https://endata.com/companies/25138.md) (partner)
- [Highsun Holdings Group](https://endata.com/companies/31929.md) (acquirer)
- [Fibrant](https://endata.com/companies/31930.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/dsm-informs-market-on-the-announced-sale-of-fibrants-caprolactam-business-to-highsun-682924701.html), 2018-05-17: "It is estimated that DSM will receive about €200 million in cash following the closing of the transaction with Highsun Holdings Group Ltd."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.